84 related articles for article (PubMed ID: 19318493)
1. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma.
Li YX; Liu QF; Fang H; Qi SN; Wang H; Wang WH; Song YW; Lu J; Jin J; Wang SL; Liu YP; Lu N; Liu XF; Yu ZH
Clin Cancer Res; 2009 Apr; 15(8):2905-12. PubMed ID: 19318493
[TBL] [Abstract][Full Text] [Related]
2. Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma.
Lee WWL; Lim JQ; Tang TPL; Tan D; Koh SM; Puan KJ; Wang LW; Lim J; Tan KP; Chng WJ; Lim ST; Ong CK; Rotzschke O
Front Immunol; 2024; 15():1346178. PubMed ID: 38680487
[TBL] [Abstract][Full Text] [Related]
3. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS
Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the prognostic capacity of baseline
Zhu YM; Peng P; Liu X; Qi SN; Wang SL; Fang H; Song YW; Liu YP; Jin J; Li N; Lu NN; Jing H; Tang Y; Chen B; Zhang WW; Zhai YR; Yang Y; Liang B; Zheng R; Li YX
Heliyon; 2024 Feb; 10(3):e25184. PubMed ID: 38322946
[TBL] [Abstract][Full Text] [Related]
6. Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Li JY; Hou XR; Chen SY; Liu X; Zhong QZ; Qian LT; Qiao XY; Wang H; Zhu Y; Cao JZ; Wu JX; Wu T; Zhu SY; Shi M; Zhang HL; Zhang XM; Su H; Song YQ; Zhu J; Zhang YJ; Huang HQ; Wang Y; He X; Zhang LL; Qu BL; Yang Y; Hu C; Deng M; Wang SL; Qi SN; Li YX
Ann Hematol; 2023 Sep; 102(9):2459-2469. PubMed ID: 37306711
[TBL] [Abstract][Full Text] [Related]
7. Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Liu X; Zhang LL; Qu BL; Zhong QZ; Qian LT; Yang Y; Hou XR; Qiao XY; Wang H; Zhu Y; Cao JZ; Wu JX; Wu T; Zhu SY; Shi M; Zhang HL; Zhang XM; Su H; Song YQ; Zhu J; Zhang YJ; Huang HQ; Wang Y; Chen F; Yin L; He X; Cai S; Li YX; Qi SN
Haematologica; 2023 Sep; 108(9):2467-2475. PubMed ID: 36951150
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
Zheng X; Qu BL; Liu X; Zhong QZ; Qian LT; Yang Y; Hou XR; Qiao XY; Wang H; Zhu Y; Cao JZ; Wu JX; Wu T; Zhu SY; Shi M; Zhang HL; Zhang XM; Su H; Song YQ; Zhu J; Zhang YJ; Huang HQ; Wang Y; Chen F; Yin L; He X; Zhang LL; Li YX; Qi SN
EJHaem; 2023 Feb; 4(1):78-89. PubMed ID: 36819187
[TBL] [Abstract][Full Text] [Related]
9. Sinonasal lymphoma: A primer for otolaryngologists.
Bitner BF; Htun NN; Wang BY; Brem EA; Kuan EC
Laryngoscope Investig Otolaryngol; 2022 Dec; 7(6):1712-1724. PubMed ID: 36544932
[TBL] [Abstract][Full Text] [Related]
10. Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.
Reneau JC; Shindiapina P; Braunstein Z; Youssef Y; Ruiz M; Farid S; Hanel W; Brammer JE
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628826
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
Bennani NN; Tun AM; Carson KR; Geiger JL; Maeda LS; Savage KJ; Rose J; Pinter-Brown L; Lunning MA; Abramson JS; Bartlett NL; Vose JM; Evens AM; Smith SM; Horwitz SM; Ansell SM; Advani RH
Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):e250-e260. PubMed ID: 34794912
[TBL] [Abstract][Full Text] [Related]
12. What Effect Does Epstein-Barr Virus Have on Extranodal Natural Killer/T-Cell Lymphoma Prognosis? A Review of 153 Reported Cases.
Tvedten E; Richardson J; Motaparthi K
Cureus; 2021 Sep; 13(9):e17987. PubMed ID: 34540511
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of lymphatic spread in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma.
Song MK; Chung JS; Oh SY; Lim SN; Lee WS; Lee SM; Kim DY
Blood Res; 2021 Jun; 56(2):72-78. PubMed ID: 34031274
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
[No Abstract] [Full Text] [Related]
15. Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients.
Liu Y; Xue K; Xia Z; Jin J; Wang J; Sun H; Lv F; Liu X; Cao J; Hong X; Guo Y; Ma X; Zhang Q
Cancer Med; 2020 Aug; 9(15):5400-5405. PubMed ID: 32519518
[TBL] [Abstract][Full Text] [Related]
16. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Chen SY; Yang Y; Qi SN; Wang Y; Hu C; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Shi M; Xu LM; Yuan ZY; Yahalom J; Tsang R; Song YQ; Zhu J; Su H; Li YX
Leukemia; 2021 Jan; 35(1):130-142. PubMed ID: 32152465
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma].
Qiu YJ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):40-46. PubMed ID: 32023753
[No Abstract] [Full Text] [Related]
18. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.
Liu X; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Qi SN; Yang Y; Li YX
JAMA Netw Open; 2019 Mar; 2(3):e190194. PubMed ID: 30821826
[TBL] [Abstract][Full Text] [Related]
19. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
[TBL] [Abstract][Full Text] [Related]
20. Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Chen B; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Qi SN; Yang Y; Liu X; Li YX
Cancer Med; 2018 Dec; 7(12):5952-5961. PubMed ID: 30358175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
